Cure8 research brief
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be an opinion or commentary related to Crohn's disease, Inflammatory bowel disease, Intestinal ultrasound, and Tests and monitoring. Use the original source link for the full details.
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declarations. Ethics approval and consent to participate: Not applicable. This article is an invited editorial and does not involve human participants, patient data or animal experiments. Consent for publication: Not applicable. Clinical trial number: Not applicable. Conflict of interest: Partha Pal received consultancy fee/speaker honorarium from Johnson and Johnson, Takeda Pharmaceutical Company, Cipla Ltd, Sun Pharma, Zydus Biosciences and Dr Reddy Labs. Kayal Vizhi Nagarajan received speaker honorarium/consultancy fee from Johnson and Johnson, Takeda Pharmaceutical Company, Sun Pharma, and Lupin Pharma. Disclaimer: The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Intestinal ultrasound. The original article is from idp.springer.com.
Based on the title and source metadata, this appears to be a guideline related to Crohn's disease, Inflammatory bowel disease, and Intestinal ultrasound. The original article is from springermedicine.com.
This study suggests intestinal ultrasound findings early after diagnosis — especially achieving “transmural remission” within 3 months — may predict better 1-year outcomes (sustained steroid-free remission and less need...
